Search This Blog

Wednesday, July 1, 2026

U.S. lawmakers open national security probe into Merck's China clinical trials and data practices

 


  • Lawmakers request detailed information on Merck's research oversight and safeguards related to its China operations.

Abivax prices its oversubscribed and upsized $800M ADS offering

 

Abivax prices its oversubscribed and upsized $800M ADS offering at $125 per share, boosting gross proceeds and extending its cash runway into Q2 2029

  • Abivax earlier halted Paris trading to finalize allocations and pricing for its ongoing U.S. ADS public offering.

Can-Fite BioPharma's Namodenoson meets primary safety endpoint in Phase 2a

Can-Fite BioPharma's Namodenoson meets primary safety endpoint in Phase 2a advanced pancreatic cancer study

  • Company plans Phase 2b trial combining Namodenoson with chemotherapy after Phase 2a showed durable survival outcomes.

https://breakingthenews.net/Article/Atlanta-Fed:-Q2-GDPNow-estimate-down-to-1.2/66614616

https://breakingthenews.net/Article/US-said-to-be-trying-to-talk-Iran-out-of-Hormuz-tolls-in-Doha/66614624

https://breakingthenews.net/Article/MicroStrategy-stock-up-11-over-new-framework/66614320

https://www.zerohedge.com/geopolitical/police-flee-during-riots-hague-after-morocco-knocks-netherlands-out-world-cup